Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 807,752
  • Shares Outstanding, K 304,812
  • Annual Sales, $ 295,670 K
  • Annual Income, $ -23,930 K
  • 60-Month Beta 1.32
  • Price/Sales 7.95
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGEN with:

Options Overview Details

View History
  • Implied Volatility 100.50% ( +3.33%)
  • Historical Volatility 71.48%
  • IV Percentile 61%
  • IV Rank 26.64%
  • IV High 237.63% on 05/11/22
  • IV Low 50.69% on 09/21/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2,111
  • Volume Avg (30-Day) 2,260
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 50,348
  • Open Int (30-Day) 81,579

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.21
  • Number of Estimates 3
  • High Estimate -0.19
  • Low Estimate -0.22
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +19.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.33 +10.54%
on 01/09/23
3.07 -16.28%
on 01/13/23
+0.17 (+7.08%)
since 01/03/23
3-Month
2.01 +27.86%
on 11/09/22
3.37 -23.74%
on 11/16/22
+0.11 (+4.47%)
since 11/03/22
52-Week
1.25 +105.60%
on 06/14/22
3.37 -23.74%
on 11/16/22
+0.19 (+7.98%)
since 02/03/22

Most Recent Stories

More News
Why Shares of Agenus Rose 12.5% on Friday

Agenus presented data this week on a combination therapy.

AGEN : 2.57 (-3.02%)
Philips (PHG) Showcases New AI-Based Solutions at the RSNA

Koninklijke Philips (PHG) banks on its new AI solutions to address issues faced by Radiology experts in the healthcare industry and drive prospects.

PHG : 17.71 (-2.85%)
AGEN : 2.57 (-3.02%)
ABEO : 2.76 (-2.13%)
ACRS : 14.05 (-1.95%)
Here Are 64 Reasons to Bet On Wednesday’s Unusual Options Activity

Eleven call contracts exhibited unusual options activity on Wednesday. I particularly like these three bets.

AGEN : 2.57 (-3.02%)
BMY : 74.45 (+2.31%)
MRK : 102.94 (-0.50%)
GILD : 84.50 (+3.82%)
PINS : 27.48 (-5.57%)
RADI : 13.99 (+1.67%)
Agenus (AGEN) Q3 2022 Earnings Call Transcript

AGEN earnings call for the period ending September 30, 2022.

AGEN : 2.57 (-3.02%)
Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates

Agenus (AGEN) delivered earnings and revenue surprises of -5.56% and 14.69%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AGEN : 2.57 (-3.02%)
CRIS : 0.7800 (+0.31%)
Agenus: Q3 Earnings Snapshot

Agenus: Q3 Earnings Snapshot

AGEN : 2.57 (-3.02%)
Bionano Genomics, Inc. (BNGO) Reports Q3 Loss, Tops Revenue Estimates

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 8.33% and 7.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

BNGO : 1.8700 (-5.08%)
AGEN : 2.57 (-3.02%)
Sarepta Therapeutics (SRPT) Reports Q3 Loss, Lags Revenue Estimates

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -142.98% and 2.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

SRPT : 119.00 (-1.04%)
AGEN : 2.57 (-3.02%)
Agenus (AGEN) Dips More Than Broader Markets: What You Should Know

Agenus (AGEN) closed at $2.51 in the latest trading session, marking a -1.57% move from the prior day.

AGEN : 2.57 (-3.02%)
Agenus (AGEN) to Report Q3 Earnings: What's in the Cards?

On Agenus' (AGEN) third-quarter earnings call, investor focus is likely to be on the company's progress with the developments of its pipeline candidates.

IMGN : 4.66 (-5.28%)
AVEO : 15.00 (unch)
AGEN : 2.57 (-3.02%)
ACAD : 19.83 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 2.73
2nd Resistance Point 2.70
1st Resistance Point 2.63
Last Price 2.57
1st Support Level 2.54
2nd Support Level 2.51
3rd Support Level 2.44

See More

52-Week High 3.37
Last Price 2.57
Fibonacci 61.8% 2.56
Fibonacci 50% 2.31
Fibonacci 38.2% 2.06
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar